Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Andreas Samson who wrote (9203)	6/5/1998 2:28:00 AM
From: VLAD	Read Replies (1) \| Respond to of 23519

Andreas, Tell me something. If Vivus was overproducing in Q3 which would have covered Q4 then Why was there shortages at local pharmacies. If you wish to check, I remember at least one poster who checked out about 4 or 5 pharmacies in Florida and was told that it was on back order from the wholesaler. If you are running three lines three shifts a day, you can bet that dismantling one line will slow down production. Some were saying back then that the shortages were giving the company and product a bad name. Also, no advertising back then so after the urologists used MUSE on regular patients who already sought treatment the demand from that pool would slacken.